by Joël Mossong Whom we meet shapes how infections spread. Where earlier focus of mathematical epidemiology was on incorporating age, more recent work has begun to reveal the importance of socioeconomic aspects for understanding and managing future epidemics. In this Perspective, Joël Mossong discusses the importance of understanding social contacts and how they have evolved for infectious disease modeling, and the need to factor in additional considerations such as ethic and socioeconomic backgrounds.
The world is falling short on health targets, with progress uneven, slowing, and in some areas reversing, according to the World Health Statistics 2026 report, published today by the World Health Organization (WHO).
Incorrect Product Formulation: product did not contain insulin as listed in the label. — Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles · Class II · Ongoing
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals. — Ajanta Pharma Ltd. · Class II · Ongoing
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test — JB Chemicals and Pharmaceuticals Ltd · Class II · Ongoing
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals. — Ajanta Pharma Ltd. · Class II · Ongoing
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. — Teva Pharmaceuticals USA, Inc · Class II · Ongoing
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals. — Ajanta Pharma Ltd. · Class II · Ongoing